“Since joining the AGITG some 20 years ago, I have gained invaluable clinical knowledge regarding the disease history of GI cancers. This together with my statistical training has enabled me to make a strong scientific contribution to clinical trials design, conduct and interpretation culminating in meta analyses in oesophageal cancer, the results of which has led to a change in clinical practice.
To be part of the AGITG is both satisfying and enriching experience, especially with the extent of scientific/clinical endeavours of the group, which is reflected in its national and global reputation as a premier collaborative trials group.”
Professor Val Gebski is the group statistician for the AGITG and a member of the AGITG Scientific Advisory Committee. In addition to this role, he is the head of Biostatistics and Research Methodology at the NHMRC Clinical Trials Centre. He completed a Master of Statistics at the University of New South Wales before joining NHMRC in 1988. He is an honorary fellow of the Royal Australian and New Zealand College of Radiologists.
In his role with the Clinical Trials Centre he directs the statistical and research methods in the oncology trials, while also contributing to wider issues of clinical trial design. He has extensive knowledge of clinical trial methodology, conduct and analysis. His research interests cover novel statistical methods of clinical trials analysis and designs examining the impact of biomarkers and biomarker driven trial designs
Val also works in curriculum development and teaching in the Masters of Public Health, Clinical Epidemiology and Medicine at the University of Sydney. He was instrumental in establishing the Biostatistical Collaboration of Australia, a national consortium of eight universities delivering postgraduate (certificate, diploma and masters) courses under a unified curriculum in biostatistics. He supervises Masters and PhD students in areas of clinical trials conduct, meta-analysis, competing risks and quality-of-life methods.
Val has worked for Independent Data Safety and Monitoring Committees, designing and implementing meta-analyses, as well as developing terms of reference for these bodies. Until recently, Val was the statistical examiner for the Royal Australian and New Zealand College of Radiologists.
Val is the coordinator of the critical appraisal component of the Basic Sciences in Oncology program run by the NSW Department of Health. He is also the Group Statistician for the Australian and New Zealand Breast Cancer Trials Group, the Australian and New Zealand Gynaecological Oncology Group and the Trans-Tasman Radiation Oncology Trials Group.